The North American Thrombosis Forum (NATF)
Avatar

AHA 2020 Trial Takeaways: Should Rivaroxaban Be Used in Patients with Bioprosthetic Valves? Can Vitamin D, Omega-3 Supplementation and Early Ablation Decrease the Incidence of Afib and Other CV Events?

By The North American Thrombosis Forum (NATF) FEATURING Christian Cruff
By The North American Thrombosis Forum (NATF) FEATURING Christian Cruff
623 views
December 17, 2020
1 Comment
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
18:36
The Texas Heart Institute

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

Feat. M. Razavi
33:34
Houston Methodist Hospital

Treatment Options for TTR Amyloid: Current and Future

Feat. R. Witteles
35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
22:57
The France Foundation

Insights into Advances in Nonvalvular Atrial Fibrillation: Exploring…

Feat. C. Ruff, J. Walker
17:29
UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
48:35
Houston Methodist DeBakey Heart and Vascular Center

"Pill in Pocket" Anticoagulation for Atrial Fibrillation: …

Feat. R. Passman
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim
34:18
Scripps Health

Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…

Feat. A. Kuo
12:30
Taya Glotzer

Management of Device Detected AF

36:11
ARCH Advanced Revascularization Symposium

The UPSTREAM Management of Aortic Stenosis in the Future

Feat. M. Leon
84:17
Jefferson Health

2022 Heart Failure Guidelines Review

Feat. D. Haas